Covid

• CDC surveillance data indicates that parainfluenza virus and human metapneumovirus levels are currently elevated across the United States this summer. • Because no vaccines exist for these two respiratory viruses, parents are advised to monitor symptoms and understand the risks associated with these infections. • In separate medical updates, a June 2026 trial suggests probiotics may enhance antidepressant efficacy for seniors, while two 2026 trials indicate Paxlovid may not significantly reduce hospitalizations for vaccinated high-risk adults.

• The FDA approved the updated COVID-19 vaccine strain in May, but official guidance on who should receive it remains unavailable. • A critical lack of a quorum since March has stalled the committee responsible for determining eligibility and insurance coverage for the fall rollout. • This administrative gap creates uncertainty for healthcare providers and patients regarding the timing and necessity of booster shots.

• A new review published in The Lancet on Tuesday confirms that mRNA vaccines from Pfizer-BioNTech and Moderna are safe and effective. • Led by Manish Sadarangani of B.C. Children's Hospital, researchers analyzed laboratory data, clinical trials, and real-world surveillance from January 2020 through December 2025. • The findings are significant because they validate the scientific and public health impact of mRNA technology during the pandemic.

• JAMA Network Open has published a taxpayer-funded study on COVID-19 vaccines that federal officials at the CDC previously declined to release. • The study examines vaccine efficacy and safety, raising questions about why the CDC initially squelched the data and whether the decision was based on political motivations or a desire to protect public confidence. • This controversy highlights ongoing tensions regarding government transparency and the potential suppression of scientific data during the pandemic response.

• A study examining COVID-19 vaccine effectiveness was finally published after being blocked from inclusion in a weekly federal government report by the CDC. • The publication follows a separate effort by Robert F. Kennedy Jr., who petitioned the FDA to revoke the authorization of all COVID-19 vaccines. • The FDA denied Kennedy's petition three months later, maintaining that vaccines are safe and effective based on clinical trials involving tens of thousands of participants.

• A study confirming the effectiveness of COVID-19 vaccines was published Tuesday by JAMA Network Open after being blocked by a CDC journal. • The research found the vaccine was approximately 55% effective against hospitalizations and reduced emergency department and urgent care visits by 50%. • The publication gained significant attention because political appointees from the Trump administration previously prevented the findings from appearing in a government health publication.

• The CDC canceled the publication of a COVID-19 vaccine effectiveness study originally scheduled for its flagship Morbidity and Mortality Weekly Report (MMWR) in April. • CDC leadership blocked the report citing "methodologic weaknesses," though the study has since been released for public review. • Dr. F. Perry Wilson of the Yale School of Medicine highlighted the incident, raising questions about transparency and the potential suppression of data by health officials.